glp 1 agonist cardioprotective The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Cardiovascular Protective Properties of GLP-1

10.1123/ijsnem.2014-0129 49

Systematic reviews of BPC-157 in musculoskeletal applications identified 36 studies demonstrating improved functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries in preclinical models

Heightened Libido

A 7-day course of AmB (1 mg/kg/day) with 5-FC (100 mg/kg/day) yields the lowest 10-week mortality (24.2%), with 5-FC outperforming fluconazole (Day et al., 2013

When the muscle beneath your injection site is contracted, the tissue is firmer, the needle meets more resistance, and nerve endings are more compressed

doi: 10.1128/AEM.02787-15 6 DeviS.SharmaM.ManhasR